Inflation that endures, geopolitical tensions, and the ongoing drive to decrease drug prices will stand as the primary obstacles for the pharmaceutical industry in 2024.
Inflation that endures, geopolitical tensions, and the ongoing drive to decrease drug prices will stand as the primary obstacles for the pharmaceutical industry in 2024.